Incyte Corporation (NASDAQ:INCY) shares went down rapidly after the company declared that its melanoma drug trial has failed. The company conducted the Phase 3 trial to establish the effectiveness of its drug epacadostat in combination with KEYTRUDA from Merck & Co., Inc.’s (NYSE:MRK) for treating patients suffering from metastatic or...
Cancer immunotherapy has a promising future despite suffering a major setback last Friday. Incyte Corporation (NASDAQ:INCY) announced that its trial drug epacadostat had failed to help melanoma patients, and the company is calling off the trial altogether. Epacadostatwas meant to work together with Keytruda, Merck & Co., Inc. (NYSE:MRK)'s blockbuster...
Ionis Pharmaceuticals Inc (NASDAQ:IONS) and Alnylam Pharmaceuticals, Inc (NASDAQ:ALNY) have for many years focused on the development of the rare-disease drug. But Thursday turned out to be a low moment for the two. That was after Pfizer Inc (NYSE:PFE), a component of Dow Jones unleashed strong late-stage results for the...
John A. Scarlett, M.D., the CEO and President of Geron Corp (NASDAQ:GERN) will present at the upcoming 17th Needham Healthcare Conference on March 27, 2018 in New York. Interested people can access the company’s website to view the live webcast of the presentation. The buzz Geron comes in the list of...
Rennova Health Inc (OTCMKTS:RNVA) has commenced its first rural hospital in Oneida, Tenn. Last year, the company’s flagship Laboratory, EPIC Reference Labs, Inc. has fulfilled the Laboratory Accreditation Program Standards from the CAP. Under the CAP Accreditation, it has been accredited for different testing services including all Common, Chemistry,...
Novavax Inc (NASDAQ:NVAX) reported the promotion of Mr. John J. Trizzino to SVP, Chief Financial Officer (CFO) and Chief Business Officer (CBO). Trizzino has been working as SVP, Commercial Operations, since 2014. As Chief Business Officer, he is now accountable for all commercial and pre-commercial launch execution and strategy...
Proteostasis Therapeutics Inc (NASDAQ:PTI) went up 22% in premarket trade on Thursday after the therapeutic company reported a less-than-expected loss for the fourth-quarter. The company further announced that the Food and Drug Administration had granted its cystic fibrosis drug orphan drug designation. The Orphan drug designation grants the company seven...
Prostate cancer is a health issue we can no longer avoid. It comes as a shocker to anyone when they discover that they have cancer.  However, a landmark study of the 4Kscore® test carried out by Opko Health Inc. (NASDAQ:OPK) seems to have something better to offer.  The 4Kscore...
Rennova Health Inc (OTCMKTS:RNVA) is the industry leading diagnostic provider which offers supportive solution programmes to other healthcare providers, giving the patients an effective experience and a proper clinical results Rennova Health Lagan made an announcement for the acquisition of its 2nd rural-based hospital The company has survived a number of...
In the last trading session, the stock price of Atossa Genetics Inc (NASDAQ:ATOS) jumped more than 40% to close the day at $0.59. The gains came at a share volume of 49.23 million compared to average share volume of 3.80 million. Post the recent gains, the market cap of...